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Abstract: The cells of the intervertebral disc (IVD) have an unusual acidic and hyperosmotic microenvironment. 
They express acid-sensing ion channels (ASICs), gated by extracellular protons and mechanical forces, as well as 
neurotrophins and their signalling receptors. In the nervous tissues some neurotrophins regulate the expression of 
ASICs. The expression of ASIC2 and TrkB in human normal and degenerated IVD was assessed using quantitative-
PCR, Western blot, and immunohistochemistry. Moreover, we investigated immunohistochemically the expression of 
ASIC2 in the IVD of TrkB-deficient mice. ASIC2 and TrkB mRNAs were found in normal human IVD and both increased 
significantly in degenerated IVD. ASIC2 and TrkB proteins were also found co-localized in a variable percentage of 
cells, being significantly higher in degenerated IVD than in controls. The murine IVD displayed ASIC2 immunoreac-
tivity which was absent in the IVD of TrkB-deficient mice. Present results demonstrate the occurrence of ASIC2 and 
TrkB in the human IVD, and the increased expression of both in pathological IVD suggest their involvement in IVD 
degeneration. These data also suggest that TrkB-ligands might be involved in the regulation of ASIC2 expression, 
and therefore in mechanisms by which the IVD cells accommodate to low pH and hypertonicity. 
Keywords: Acid-sensing ion channel 2, neurotrophin receptor TrkB, human intervertebral disc, degenerate in-
tervertebral disc, TrkB-deficient mice
Introduction
The intervertebral disc (IVD) is a cartilaginous 
joint placed between two consecutive verte-
brae consisting of a central gelatinous nucleus 
surrounded by an outer fibrous structure called 
nucleus pulposus (NP) annulus fibrosus (AF), 
respectively. The adult human IVD contains dif-
ferent types of cells similar to fibroblasts in AF, 
and similar to chondrocytes in NP, distributed 
alone or in groups within the extracellular 
matrix (ECM) [1, 2]. The cells in IVD have an 
unusual microenvironment because ECM is 
rich in negatively charged proteoglycans, which 
attract cations creating a high extracellular 
osmolarity. Furthermore, the IVD cells have an 
active anaerobic metabolism leading to the 
accumulation of lactate and low values of pH 
[3]. Among the molecular mechanisms involved 
in maintaining cell survival in these adverse 
conditions are different families of ion chan-
nels [4]. In cells similar to those of the NP these 
ion channels participate not only in preserva-
tion of cells against adverse pH and pressure, 
but also in regulating the production of ECM 
compounds [5-7] and cell survival [8, 9].
Acid-sensing ion channels (ASICs), are a family 
of cation-selective channels gated by extracel-
lular protons, which mediate an increase in 
intracellular Ca2+ upon exposure to acidic condi-
tions and can be gated by mechanical forces 
[10, 11]. Articular chondrocytes [12-15] as well 
as IVD cells express different ASIC proteins [16-
18], which are required for cell survival in a low 
pH and hyperosmotic medium.
On the other hand, members of the neurotro-
phin (NT) family of growth factors, as well as 
their signalling receptors, have been detected 
in IVD where presumably regulate the density of 
innervation and are involved in the genesis of 
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the discogenic pain [19-24]. In particular, the 
brain-derived neurotrophic factor (BDNF) and 
its signalling receptor TrkB are present in native 
chondrocytes of human IVD, thus suggesting 
an autocrine or paracrine role of BDNF in regu-
lation of IVD cell biology [19-23]. Interestingly, 
NTs influence the expression of ASICs, and 
ASICs co-localize with NT receptors in the 
peripheral nervous system [see for a review 
24]. Recently, it was also demonstrated that 
the pan-neurotrophin receptor p75NTR partici-
pates in the regulation of ASIC3 basal promoter 
activity in the IVD cells [16], and TrkB co-localiz-
es with ASIC3 in cells isolated from degenerat-
ed IVD [22]. 
Based on the above data, we have designed 
this study to determine the occurrence and dis-
tribution of ASIC2 and TrkB in the human nor-
mal and degenerate IVD using quantitative-
PCR, Western blot and immunohistochemistry. 
Moreover, we used IVD from TrkB-deficient 
mice to analyze the immunohistochemical 
expression of ASIC2 in IVD in absence of this 
NT receptor. The study was undertaken to 
investigate whether or not NTs regulate pro-
teins involved in the mechanisms by which IVD 
cells accommodate to the low pH and hyperto-
nicity, and the involvement of ASIC2 and TrkB in 
IVD degeneration. 
Material and methods
Human material and treatment of the tissues 
Lumbar human IVDs were obtained from sub-
jects of both sexes (21 males, 17 females; age 
range 46 to 73 years) during surgical proce-
dures to remove IVD for treatment of low back 
pain due to IVD degeneration from the Servicio 
de Neurocirugía, Complejo Asistencial Univer- 
sitario de León (Leon, Spain) and Hospital 
Universitario Central de Asturias (HUCA, Oviedo, 
Spain). The material corresponded to grades II 
(n = 8), III (n = 8), IV (n = 12) and V (n = 10) of 
the Thompson scale of IVD degeneration [25]. 
Moreover, freshly lumbar IVD were obtained 
from subjects free of low back pain history, who 
had died in traffic accidents (n = 8, males; age 
range 38-52 years) during removal of organs 
for transplantation (HUCA); they were consid-
ered grade I of the Thompson scale. The col-
lected material was divided into several seg-
ments containing both AF and NP tissue. Some 
specimens (2 blocks 1 cm3 approximately from 
each subject) were fixed in 4% formaldehyde in 
0.1 M phosphate buffer saline (pH 7.4) for 24 h, 
dehydrated and embedded in paraffin, sec-
tioned 10 μm thick, and the sections mounted 
on gelatine-coated microscope slides. Fresh 
samples (4 blocks 0.5 cm3 approximately from 
each subject) were quickly frozen and stored at 
-80°C until used. All the tissues used in the pre-
sent study were obtained in compliance with 
Spanish Law and the guidelines of the Helsinki 
Declaration II. 
Mice material and treatment of the tissues 
The spines used in the present study were kind-
ly provided by Dr. I. Silos-Santiago, and were 
obtained from mice described elsewhere [26]. 
Wild type (n = 4, TrkB +/+), and homozygous 
TrkB-deficient mice (n = 5, TrkB -/-) were stud-
ied at 15 days postnatally which is at the limit 
of the survival. Animals were euthanized with 
an overdose of chloral hydrate and were per-
fussed transcardially with a cold solution of 4% 
paraformaldehyde in 0.1 M PBS, pH 7.4. Then, 
the lumbar spine was removed and placed into 
the same perfusion fixative. The samples were 
processed for routine paraffin embedding, sec-
tioned at 10 μm thick, and the sections mount-
ed on gelatin-coated microscope slides. 
Quantitative PCR
The technical procedure was described in detail 
previously [17]. The sequences of the oligonu-
cleotide primers were based upon the pub-
lished sequences for Homo sapiens TrkB 
(GeneBank accession number NM_00100- 
7097.1) and Homo sapiens ASIC2 (GeneBank 
accession number NM_001094), and were: for 
TrkB forward: 5’-gatcctgagaacatcccga-3’, rever- 
se: 5’-caccaggatcagttcagac-3’; for ASIC2 for-
ward: 5’-accaccaatgacctgtacca-3’, reverse: 5’- 
gccctttgaacttgcagtag-3’. The homemade Taq-
Man probes were labelled at the 50 with 60FAM 
fluorochromes for the ASIC2 and TrkB, and VIC 
fluorochrome for β-actin, while the 30 ends 
were labelled with the Minor Grow Binder (MGB) 
quencher. The assays were performed in tripli-
cate using a 7500 PCR real-time System 
(Applied Biosystems), and quantification was 
calculated using the 2-DDCt algorithm. The 
average value in grade I IVD was considered as 
the standard, and the final results were 
expressed as ± n-fold difference versus stand-
ard (relative expression). Statistical differences 
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among experimental groups with respect to the 
standard were performed using analysis of vari-
ance (ANOVA). P-values less than 0.05 were 
considered significant.
Western blot
Western blot analysis was performed in frozen 
IVD samples containing both AF and NP tissue 
as described earlier [17]. The anti-TrkB anti-
body (Santa Cruz Biotechnology, Santa Cruz, 
CA, USA; TrkB [794]: sc-12) was raised in rabbit 
and used diluted 1:100 in the blocking buffer. 
This antibody is directed against the residues 
794-808 of the intracytoplasmatic domain of 
human TrkB. The anti-ASIC2 antibody (Lifespan 
Biosciences, Seattle, WA, USA; LS-B156/12883) 
was raised in rabbit and used diluted 1:200. It 
was raised against a synthetic peptide from the 
extracellular domain of mouse ASIC2 conjugat-
ed to an immunogenic carrier protein.
Single immunohistochemistry
Sections from human and mice IVD were pro-
cessed for detection ASIC2 and TrkB using the 
EnVision antibody complex detection kit (Dako, 
Copenhagen, Denmark), following supplier’s 
instructions, as reported earlier [17]. The sec-
tions were incubated overnight at 4°C with pri-
mary antibodies described above both used 
diluted 1:100. 
Double immunohistochemistry
To investigate whether or not ASIC2 and TrkB 
co-localized, and to establish the percent of 
chondrocytes expressing each protein, IVD sec-
tions were processed for alternative detection 
of ASIC2 and TrkB. Non-specific binding was 
reduced by incubation for 30 minutes with a 
solution of 1% bovine serum albumin in Tris 
buffer solution (TBS). The sections were then 
processed as follow: in the first step were incu-
bated overnight at 4°C in a humid chamber 
with anti-ASIC2 antibody diluted 1:200, then 
rinsed with TBS, and incubated for 1 hour with 
Alexafluor 546-conjugated goat anti-rabbit IgG 
(Serotec, Oxford, UK), diluted 1:1000 in TBS, 
then rinsed again; in a the second step sec-
tions were incubated overnight at 4°C in a 
humid chamber with anti-TrkB antibody diluted 
1:100, then rinsed with TBS, and incubated for 
1 hour with Alexafluor 488-conjugated goat 
anti-rabbit IgG (Serotec, Oxford, UK), diluted 
1:1000. Both steps were performed at room 
temperature in a dark humid chamber. 
Moreover the sections were incubated with 
DAPI (diluted in glycerol medium, 10 ng/ml) to 
ascertain that immunoreactivity occurred in 
the cells and not in ECM. Fluorescence were 
detected using a Leica DMR-XA microscope 
coupled with a Leica Confocal Software, ver-
sion 2.5 (Leica Microsystems, Heidelberg 
GmbH, Germany) and the images captured 
were processed using the software Image J ver-
sion 1.43 g Master Biophotonics Facility, Mac 
Master University Ontario (www.macbiophoton-
ics.ca).
For control purposes sections were processed 
in the same way as described above using spe-
cifically preabsorbed antisera (5 µg/ml of the 
ASIC2 blocking peptide-Lifespan Biosciences 
LS-PB156 in the working solution; 10 µg/ml of 
the TrkB blocking peptide-sc-12P, Santa Cruz 
Biotechnology- in the working solution). Under 
these conditions no positive immunostaining 
was observed (data not shown). 
Quantitative study
The percentage of cells in AF and NP displaying 
immunoreactivity for ASIC2 or TrkB was calcu-
lated automatically in 5 randomly selected 
fields per section, 10 sections per specimen 
100 μm apart to avoid count a cell twice. 
Counts were carried out using an automatic 
image analysis system (Quantimet 550, Leika, 
QWIN Program, Servicio de Análisis de 
Imágenes, University of Oviedo). The total num-
ber of cells was established by counting num-
ber of DAPI positive nuclei, and the percentage 
of the cells immunoreactive determined on the 
basis of the association of ASIC2 or TrkB immu-
noreactivity and DAPI in the same cell. The per-
centage of ASIC cells was calculated automati-
cally and the data expressed as mean ± S.E.M. 
The data were tested for normality using the 
Shapiro-Wilke W method of analysis, and as 
they did not follow a normal distribution, a two-
sided Mann-Whitney U test was carried out to 
determine differences between the percentage 
of ASIC2 or TrkB positive cells in the normal and 
degenerate IVDs. A Wilcoxin test was used to 
identify significance between the different 
regions of the IVD (NP and AF). P < 0.05 was 
considered significant. Values of P < 0.05 were 
considered as significant. 
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Results
TrkB and ASIC2 mRNAs 
are present in normal 
and degenerated hu-
man IVD
The expression of ASIC2 
was analyzed in sam-
ples of human IVD, 
graded from I to V in the 
Thompson’s scale. Con- 
sidering grade I as the 
standard, there was a 
significant increase of 
ASIC2 expression in all 
grades of degenerated 
IVD, but this increase 
was not linearly corre-
lated with the grade of 
degeneration (Figure 
1A). Regarding the ex- 
pression of TrkB, and 
considering also as a 
standard the levels ob- 
tained in grade I, there 
was a significant incre- 
ase in the TrkB expres-
sion in all groups of 
degenerated IVD, reach-
ing maximal values in 
grades IV and V (Figure 
1B). 
Figure 1. Relative mRNA levels of ASIC2 (A) and TrkB (B) in degenerated human intervertebral disc in relation to the 
grade I of Thompson’s.
Figure 2. Western blot detection of TrkB and ASIC2 in homogenates of normal hu-
man intervertebral disc (A). The anti-TrkB antibody used recognizes a single protein 
band of 145 kDa consistent with full-length TrkB. The anti-ASIC2 antibody used 
labels two protein bands of estimated molecular weights of 72 kDa and 55 kDa. By 
immunohistochemistry a variable number of cells in normal (B, C) and degenerated 
(D, E, Thompson’s III grade) IVD, in both the nucleus pulposus and the annulus 
fibrosus, displayed ASIC2 (B, D) and TrkB (C, E). Scale bar = 15 µm for (B, C); 10 
µm for (D, E). 
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TrkB and ASIC2 proteins are present in normal 
and degenerate human IVD
Western blot analysis of ASIC2 in homogenates 
of normal and degenerated human IVD indi-
cates the presence of two protein bands whose 
estimated molecular weight were of 72 kDa 
and 55 kDa, respectively (Figure 2A). Regarding 
TrkB, Western blot in homogenates of normal 
noreactive cells between AF and NP were 
observed. 
In grade I the percentage of TrkB positive cells 
was significantly greater (in the NP (42.01 ± 
6.3) compared with AF (19.21 ± 2.9). In the sec-
tions from degenerated IVD the density of TrkB 
positive cells markedly increased in both AF 
and NP, which progressively increased with the 
Figure 3. Percentage of cells displaying ASIC2 (A) and TrkB (B), and co-localization 
of TrkB-ASIC2 (C) in the anullus fibrosus (AF) and nucleus pulposus of grade I and 
degenerated human intervertebral disc. Degeneration was graded following the 
Thompson’s scale. 
human IVD shows the 
existence of a single 
protein band with an 
estimated molecular 
weight of 145 kDa, 
which is the expected 
for the full-length iso-
form of TrkB (Figure 
2A). 
Consistently, in both 
normal and degenerat-
ed IVD positive immu-
noreactivity was obse- 
rved in sections pro-
cessed for detection of 
TrkB and ASIC2, and in 
both cases cells dis-
playing immunostain-
ing were identified as 
chondrocyte-like cells 
of the NP and as fibro-
blast-like cells of the AF 
(Figures 2B-E, 3). 
The percentage of 
ASIC2 positive cells in 
the grade I was signifi-
cantly greater (P < 
0.05) in the NP (78.1 ± 
12.6) compared with 
AF (38.2 ± 6.4). In the 
samples from degener-
ated IVD the density of 
ASIC2 positive cells did 
no changed significant-
ly in AF for none of the 
groups whereas there 
were non-significant 
changes in the NP of 
stages II and III, and 
significant increases in 
stages IV and V (Figure 
4A). From II to V stages 
significant differences 
in the percent of immu-
ASIC2 and TrkB in intervertebral disc
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grade of Thompson’s scale. All the differences 
were statistically significant with respect to the 
grade I in both AF and NP, and also between 
stages II and III vs. IV and V (Figure 4B). From II 
to V stages significant differences in the per-
cent of immunoreactive cells between AF and 
NP were observed. 
Co-localization of ASIC2 and TrkB in normal 
and degenerated human IVD 
The co-localization of TrkB and ASIC2 paral-
leled the data reported for ASIC and TrkB indi-
vidually. Merge ASIC2-TrkB immunoreactivity 
results in yellow in the whole cytoplasm or in a 
segment of the cytoplasm. AF of normal IVD 
showed a low percentage of cells displaying 
ASIC2-TrkB co-localization (Figure 4C), while in 
NP almost all the ASIC2 positive cells also were 
TrkB positive (Figure 4C; P < 0.001). Regarding 
the degenerated IVD, co-localization of TrkB 
and ASIC2 was observed in a variable percent-
age of cells. In AF significant differences (P < 
0.001) were found in stages II to V with respect 
to the stage I, thus almost all TrkB positive cells 
were also ASIC2 positive. In NP the percentage 
of cells showing ASIC2-TrkB co-localization 
ranged from around 60% in grades IV and V to 
around 35% in grades II and III of the 
Thompson’s scale (Figure 4C), and all the dif-
ferences were statistically significant. From I to 
V stages significant differences in the percent 
of immunoreactive cells between AF and NP 
were observed. 
Figure 4. Immunohistochemical detection of ASIC2 and TrkB in cells of the nucleus pulposus (6) of normal human 
IVD. Co-localization of both proteins was evident in the nucleus pulposus cells. Scale bar: 10 µm. 
ASIC2 and TrkB in intervertebral disc
10311 Int J Clin Exp Pathol 2015;8(9):10305-10314
ASIC2 expression in mouse IVD of TrkB defi-
cient mice
To elucidate whether TrkB and their ligands 
might regulate the expression of ASIC2 in cells 
of IVD, we have investigated immunohisto-
chemically the occurrence of ASIC2 in IVD of 
wild-type and TrkB deficient mice. In wild-type 
animals, two weeks old, there was faint ASIC2 
immunostaining in the AF cells, which was more 
evident in the chondrocyte-like cells of NP. 
Conversely in the IV from functionally deficient 
TrkB mice there was a complete absence of 
ASIC2 immunostaining (Figure 5).
Discussion 
The cells of the human IVD are embedded in an 
unusual microenvironment characterized by 
low pH and a high extracellular osmolarity [3]. 
Moreover, they are exposed to a wide range of 
mechanical loads, mainly hydrostatic pressure 
in NP and tensile strain in AF [see for a review 
27]. Consequently, the cells in IVD have devel-
oped different strategies for survival including 
the expression of different families of ion chan-
nels [4]. ASICs are cation selective channels 
that work as acid-sensors and mechanosen-
sors [10, 12, 13, 15], and they have been 
detected in the IVD cells [16, 17, 28]. On the 
other hand, it is well documented that NTs influ-
ence expression of ASIC2 in the sensory neu-
rons of the peripheral nervous system [29-32], 
and of ASIC3 in cultures of IVD cells [16]. 
Based on these data we designed the present 
study to investigate the occurrence of ASIC2 
and TrkB in the normal and degenerated human 
IVD, and whether or not the ligands of TrkB, i.e. 
BDNF and/or NT-4, may regulate the expres-
sion of ASIC2 in the IVD cells. The changes in 
the expression of these proteins, and its 
mRNAs, in degenerated human IVD were also 
investigated, as well as the absence of TrkB in 
the expression of ASIC2 by the IVD cells. 
Our results demonstrate ASIC2 at the mRNA 
and protein levels in normal IVD, the density of 
ASIC2 positive cells being greater in NP than in 
AF. These data are in total agreement with a 
previous study from our group [17], and add 
new data about the presence of members of 
ASIC family in the IVD [16, 18, 28]. TrkB mRNA 
and TrkB full-length protein as well as TrkB pos-
itive cells were also found in normal human 
IVD, being greater the percentage of cells in the 
NP than in the AF. These findings are in good 
agreement with previous studies reporting the 
occurrence of TrkB in a subpopulation of IVD 
cells [20-23]. Interestingly co-localization of 
ASIC2 and TrkB was detected in IVD cells in 
both the AF and NP; similarly, co-localization of 
ASIC3-TrkB in cultured NP cells has been shown 
[22]. 
Figure 5. Structure and immunohistochemical detection of ASIC2 in the lumbar IVD of wild-type (A-C) and TrkB-de-
ficient mice (D-F). The absence of TrkB abolished the expression of ASIC2 by the annulus fibrosus (AF) and nucleus 
pulposus (np) cells. Scale bar: 1 mm for (A and D); 20 µm for (B, C, E and F). 
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In degenerated IVD, we observed increased lev-
els of ASIC2 mRNA and higher density of cells 
showing ASIC2 immunoreactivity with respect 
to the controls, as previously reported [17]. 
These findings suggest that high levels of ASIC2 
seem to be related to IVD degeneration. At pre-
sent is difficult to link changes in ASIC2 expres-
sion with IVD degeneration. Presumably, ASIC2 
has a similar role as in articular chondrocytes 
[6-9, 13-15, 33-35] altering ECM composition 
and cell survival that occur in IVD degradation. 
However, a definitive role of ASIC2 in cells of 
IVD remains to be established. 
The TrkB mRNA and the number of cells display-
ing TrkB immunoreactivity also increased in 
degenerated human IVD, especially in the more 
advanced grades. Globally our results are in 
good agreement with previous studies by 
Purmessur et al. [21] although we have 
observed that the increase in TrkB correlates 
with the grade of IVD degeneration, while these 
authors do not. Recently increased levels of 
BDNF and TrkB have been found in degenerat-
ed [23] and painful whole body vibration [36] 
human IVD. 
In our study, the increased expression of ASIC2 
and TrkB in degenerated IVD were basically par-
allel, thus leading support to a close relation-
ship between them within the IVD, and to a pos-
sible regulation of ASIC2 expression by the TrkB 
ligands, as it occurs in the peripheral nervous 
system. Interestingly, elevated values of BDNF 
were found in degenerated IVD [21, 22, 37]. 
Additional support for a control of ASIC2 for 
TrkB and their ligands was provided by our 
results in TrkB deficient mice, since ASIC2 posi-
tive cells is absent from IVD in these animals 
whereas it is present in the wild-type ones. 
The results reported here expands our knowl-
edge about the role of TrkB and their ligands in 
the human IVD although further studies are 
necessaries to clarify the networks involved in 
the regulation of IVD cell survival in normal con-
ditions and the changes when IVD degenerate. 
Although the occurrence of TrkB and BDNF in 
human IVD suggest that autocrinia and/or par-
acrinia exists in this organ, and therefore, other 
molecules than NTs surely control the expres-
sion of ASICs in the IVD. It is know that NTs are 
expressed in non-neuronal tissues, including 
the IVD [24] but few studies have examined the 
function of NTs in non-neural cells.
In our study we have regularly found that NP 
cells were more affected that AF cells in IVD 
degeneration. Probably these differences 
reflects the different degeneration manner of 
the each IVD components [2, 38] and the differ-
ent sensitivity of AF and NP cells to mechanical 
forces, changing the biological responses 
according the cell type and the properties of 
loading [27]. This might explain at least in part 
the differences in the expression of ASICs 
found between AF and NP during IVD 
degeneration. 
As summary, all together data from the present 
study indirectly argues for a functional interac-
tion between TrkB and ASIC2, but in the 
absence of further experimental procedures it 
remains to be definitively demonstrated. 
Experiments are in progress, in our laboratory, 
to elucidate the mechanisms throughout this 
regulation occur. Finally and overall, we report 
unprecedented data about expression of ASIC2 
in IVD.
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